Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Stemtech (STEK) EBIT Margin (2020 - 2025)

Stemtech's EBIT Margin history spans 5 years, with the latest figure at 39.8% for Q3 2025.

  • For Q3 2025, EBIT Margin rose 2965.0% year-over-year to 39.8%; the TTM value through Sep 2025 reached 48.55%, up 2684.0%, while the annual FY2024 figure was 47.22%, 3862.0% up from the prior year.
  • EBIT Margin for Q3 2025 was 39.8% at Stemtech, up from 43.13% in the prior quarter.
  • Across five years, EBIT Margin topped out at 2.52% in Q4 2024 and bottomed at 323.05% in Q3 2022.
  • The 5-year median for EBIT Margin is 69.45% (2024), against an average of 79.05%.
  • The largest annual shift saw EBIT Margin tumbled -24201bps in 2022 before it surged 27845bps in 2023.
  • A 5-year view of EBIT Margin shows it stood at 138.76% in 2021, then skyrocketed by 71bps to 40.04% in 2022, then crashed by -162bps to 104.79% in 2023, then surged by 102bps to 2.52% in 2024, then crashed by -1677bps to 39.8% in 2025.
  • Per Business Quant, the three most recent readings for STEK's EBIT Margin are 39.8% (Q3 2025), 43.13% (Q2 2025), and 138.81% (Q1 2025).